UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE MONTH OF NOVEMBER 2025
COMMISSION FILE NUMBER 001-38976
Genmab A/S
(Exact name
of Registrant as specified in its charter)
Carl Jacobsens Vej 30
2500 Valby
Denmark
+45 70 20 27 28
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXHIBIT INDEX
|
|
|
| Exhibit |
|
Description of Exhibit |
|
|
| 99.1 |
|
Announcement, dated November 10, 2025. |
|
|
| 99.2 |
|
Announcement, dated November 10, 2025. |
|
|
| 99.3 |
|
Excerpts from Preliminary Offering Memorandum. |
|
|
| 99.4 |
|
Unaudited Pro Forma Condensed Combined Financial Information from the Preliminary Offering Memorandum. |
|
|
| 99.5 |
|
Audited consolidated financial statements as of and for the years ended December
31, 2024, 2023 and 2022, originally prepared in Danish Kroner and retranslated into United States Dollars for all periods presented. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
| GENMAB A/S |
|
|
| BY: |
|
/s/ Anthony Pagano |
|
|
Name: Anthony Pagano |
|
|
Title: Executive Vice President & Chief Financial Officer |
DATE: NOVEMBER 12, 2025
